Literature DB >> 8285240

NMR measurements of Na+ and cellular energy in ischemic rat heart: role of Na(+)-H+ exchange.

M M Pike1, C S Luo, M D Clark, K A Kirk, M Kitakaze, M C Madden, E J Cragoe, G M Pohost.   

Abstract

Interleaved 23Na- and 31P-nuclear magnetic resonance (NMR) spectra were continuously collected on perfused rat hearts subjected to low-flow ischemia (30 min, 10% flow) or zero-flow ischemia (21 min) followed by reperfusion. During untreated low-flow and zero-flow ischemia, intracellular Na+ (Nai+) increased by 53 +/- 11 (+/- SE) and 78 +/- 8%, respectively, and remained elevated for zero-flow hearts. However, during both low- and zero-flow ischemia, Nai+ did not increase in hearts treated with the Na(+)-H+ exchange inhibitor, 5-(N-ethyl-N-isopropyl)amiloride (EIPA). The pH decreases during ischemia were unchanged. EIPA treatment reduced ATP depletion during ischemia. During reperfusion from zero-flow ischemia, EIPA-treated hearts displayed more rapid and extensive recoveries of phosphocreatine and ATP. Recovery of left ventricular developed pressure was improved for zero-flow hearts treated with EIPA during the ischemic period exclusively (104 +/- 13%) compared with untreated hearts (36 +/- 21%). These data indicate that Na(+)-H+ exchange is an important mechanism for Nai+ accumulation, but not for pH regulation, during myocardial ischemia. Additionally, Nai+ homeostasis plays an important role in the postischemic recovery of cellular energy and ventricular function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8285240     DOI: 10.1152/ajpheart.1993.265.6.H2017

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  33 in total

Review 1.  Development of the Na+/H+ exchange inhibitor cariporide as a cardioprotective drug: from the laboratory to the GUARDIAN trial.

Authors:  W Scholz; A Jessel; U Albus
Journal:  J Thromb Thrombolysis       Date:  1999-07       Impact factor: 2.300

Review 2.  Regulation of cardiac sarcolemmal Na+/H+ exchanger activity: potential pathophysiological significance of endogenous mediators and oxidant stress.

Authors:  M Avkiran; A K Snabaitis
Journal:  J Thromb Thrombolysis       Date:  1999-07       Impact factor: 2.300

3.  A single cell model of myocardial reperfusion injury: changes in intracellular Na+ and Ca2+ concentrations in guinea pig ventricular myocytes.

Authors:  T Nakamura; H Hayashi; H Satoh; H Katoh; M Kaneko; H Terada
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

4.  Multinuclear MR-spectroscopy on ion-homeostasis and energetics during ischemia and reperfusion.

Authors:  U K Decking; L Vogler; M Hartmann; J Schrader
Journal:  MAGMA       Date:  2000-11       Impact factor: 2.310

5.  Remodeling of connexin 43 in the diabetic rat heart.

Authors:  Hai Lin; Koichi Ogawa; Issei Imanaga; Narcis Tribulova
Journal:  Mol Cell Biochem       Date:  2006-04-22       Impact factor: 3.396

6.  Effects of HNS-32, a novel antiarrhythmic drug, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats.

Authors:  M Saitoh; N N Aye; S Komori; T Nakazawa; K Hashimoto
Journal:  Mol Cell Biochem       Date:  2000-02       Impact factor: 3.396

7.  Preconditioning rabbit cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis.

Authors:  R A Gottlieb; D L Gruol; J Y Zhu; R L Engler
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

Review 8.  The role of Na+/H+ exchange in ischemia-reperfusion.

Authors:  H M Piper; C Balser; Y V Ladilov; M Schäfer; B Siegmund; M Ruiz-Meana; D Garcia-Dorado
Journal:  Basic Res Cardiol       Date:  1996 May-Jun       Impact factor: 17.165

Review 9.  Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion.

Authors:  Giancarlo Solaini; David A Harris
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

10.  Na/H exchange inhibition protects newborn heart from ischemia/reperfusion injury by limiting Na+-dependent Ca2+ overload.

Authors:  Hong Liu; Peter M Cala; Steve E Anderson
Journal:  J Cardiovasc Pharmacol       Date:  2010-03       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.